Table of Contents Author Guidelines Submit a Manuscript
International Journal of Biomedical Imaging
Volume 2017, Article ID 6141734, 14 pages
Review Article

Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology

1Department of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2Medical Bioengineering Department, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
3Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran
4School of Engineering-Emerging Technologies, University of Tabriz, Tabriz, Iran
5Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran

Correspondence should be addressed to Behzad Abedi; moc.liamg@3991ideba.dazheb and Sabalan Daneshvar;

Received 1 August 2016; Revised 20 December 2016; Accepted 5 January 2017; Published 19 February 2017

Academic Editor: Richard H. Bayford

Copyright © 2017 Hamid Tayebi Khosroshahi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


At the present time, imaging guided renal biopsy is used to provide diagnoses in most types of primary and secondary renal diseases. It has been claimed that renal biopsy can provide a link between diagnosis of renal disease and its pathological conditions. However, sometimes there is a considerable mismatch between patient renal outcome and pathological findings in renal biopsy. This is the time to address some new diagnostic methods to resolve the insufficiency of conventional percutaneous guided renal biopsy. Nanotechnology is still in its infancy in renal imaging; however, it seems that it is the next step in renal biopsy, providing solutions to the limitations of conventional modalities.